|
Volumn 128, Issue 6, 2006, Pages 395-404
|
Effect of genetic polymorphism of cytochrome P450 3A and transporter gene on pharmacokinetics of tacrolimus, a calcineurin inhibitor
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCINEURIN INHIBITOR;
CYTOCHROME P450;
CYTOCHROME P450 3A4;
CYTOCHROME P450 3A5;
MULTIDRUG RESISTANCE PROTEIN 1;
TACROLIMUS;
CYP3A4 PROTEIN, HUMAN;
CYP3A5 PROTEIN, HUMAN;
GLYCOPROTEIN P;
IMMUNOSUPPRESSIVE AGENT;
AFRICAN AMERICAN;
ALLELE;
AMINO ACID SUBSTITUTION;
CAUCASIAN;
CHINA;
DRUG METABOLISM;
FRANCE;
GENE ACTIVITY;
GENETIC POLYMORPHISM;
GENOTYPE;
HEART ARRHYTHMIA;
HETEROZYGOTE;
HUMAN;
JAPAN;
KIDNEY GRAFT;
NETHERLANDS;
PHARMACOKINETICS;
POLAND;
REVIEW;
GENETICS;
CYTOCHROME P-450 ENZYME SYSTEM;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
P-GLYCOPROTEIN;
POLYMORPHISM, GENETIC;
TACROLIMUS;
|
EID: 38849177023
PISSN: 00155691
EISSN: 13478397
Source Type: Journal
DOI: 10.1254/fpj.128.395 Document Type: Review |
Times cited : (6)
|
References (56)
|